GlaxoSmithKline Pharmaceuticals Limited — Others, 06-08-2025: News Verification

GlaxoSmithKline Pharmaceuticals Limited has clarified a recent news report concerning 'Trump Tariff News' and calls for companies to cut US prices. The company states that the news item, which appeared on moneycontrol.com, pertains to GSK plc, its ultimate parent company in the UK, and not to GlaxoSmithKline Pharmaceuticals Limited (the Indian entity). The Indian company has no further information regarding the events in the article and is not aware of any impact on its operations or share price. This clarification assures investors the reported issues do not directly involve the Indian subsidiary.